{"category":{"kind":"product_category","slug":"oncology","name":"Oncology","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-05T04:09:36.463Z","updated_at":"2026-09-05T04:09:36.463Z","example":false,"profile_url":"/categories/oncology","is_stub":true,"member_count":20,"member_counts":{"product":20}},"members":[{"listing_type":"product","name":"Porustobart","slug":"porustobart","tagline":"Engineered CTLA-4 antibody for neoadjuvant immuno-oncology","description":"Porustobart is Solstice Oncology's investigational second-generation heavy-chain-only CTLA-4 antibody being studied in combination with anti–PD-1 therapy in the neoadjuvant setting, starting with MSS stage III colon cancer.","url":"https://www.solsticeoncology.com/","is_stealth":false,"normalized_domain":"solsticeoncology.com","normalized_url_key":"solsticeoncology.com","parent_slug":"solstice-oncology","parent":{"slug":"solstice-oncology","name":"Solstice Oncology","listing_type":"company","profile_url":"/companies/solstice-oncology"},"type_data":{"product_kind":"other"},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.solsticeoncology.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.solsticeoncology.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Oncology","Health"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-10T08:21:25.406Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-10T08:21:25.406Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"health","name":"Health","note":null,"profile_url":"/categories/health"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-10T08:21:25.406Z","updated_at":"2026-09-10T08:21:25.406Z"}},{"listing_type":"product","name":"Numerion Labs","slug":"numerion-labs-platform","tagline":"An AI drug discovery platform that uses machine learning to explore chemical space and identify novel small molecules for immune and inflammatory diseases.","description":"Numerion Labs operates an AI superplatform that explores the vast universe of chemical space to discover novel, drug-like small molecules with first- and best-in-class potential, currently focused on immune and inflammatory diseases. The platform unites computational chemistry, structural biology, and medicinal chemistry through cutting-edge machine learning algorithms to deliver candidates not seen by conventional discovery approaches.\n\nNumerion Labs is a product of Numerion Labs.","url":"https://numerionlabs.ai/","is_stealth":false,"normalized_domain":"numerionlabs.ai","normalized_url_key":"numerionlabs.ai","parent_slug":"numerion-labs","parent":{"slug":"numerion-labs","name":"Numerion Labs","listing_type":"company","profile_url":"/companies/numerion-labs"},"type_data":{"product_kind":"saas","open_source":false,"use_cases":["AI-powered drug discovery","Small molecule identification","Immune disease drug programs","Inflammatory disease drug programs","Computational chemistry"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://numerionlabs.ai/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://numerionlabs.ai/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Drug Discovery","Biotech","AI","Healthcare","Drug Discovery and Delivery","AI-powered Drug Discovery","Deep Learning","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:46:42.454Z","added_via":"web","geo":{"keywords":["Numerion Labs","Numerion Labs","Drug Discovery","Biotech","AI","Healthcare","Drug Discovery and Delivery","AI-powered Drug Discovery","Deep Learning","Oncology"],"canonical_facts":["Product of Numerion Labs"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:46:42.454Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/categories/ai-powered-drug-discovery"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"deep-learning","name":"Deep Learning","note":null,"profile_url":"/categories/deep-learning"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:46:42.454Z","updated_at":"2026-09-05T07:46:42.454Z"}},{"listing_type":"product","name":"OncoPrism","slug":"oncoprism","tagline":"An RNA-Seq-based diagnostic assay that predicts cancer patient response to immunotherapy before treatment begins.","description":"OncoPrism is Cofactor Genomics' flagship diagnostic that uses multidimensional RNA biomarkers to predict whether patients will respond to immunotherapy, addressing the limitations of single-analyte biomarkers. It is being evaluated in the national PREDAPT trial across 11 solid tumor cancers with 24+ healthcare systems participating. The assay aims to give clinicians and patients a more accurate understanding of tumor response ahead of treatment decisions.\n\nOncoPrism is a product of Cofactor Genomics.","url":"https://cofactorgenomics.com/","is_stealth":false,"normalized_domain":"cofactorgenomics.com","normalized_url_key":"cofactorgenomics.com","parent_slug":"cofactor-genomics","parent":{"slug":"cofactor-genomics","name":"Cofactor Genomics","listing_type":"company","profile_url":"/companies/cofactor-genomics"},"type_data":{"product_kind":"service","free_tier":false,"open_source":false,"use_cases":["Predicting immunotherapy response","Pre-treatment tumor analysis","Guiding cancer treatment decisions","Clinical trial research"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://cofactorgenomics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://cofactorgenomics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Biotech","Oncology","Genomics","Medical Devices"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:46:01.904Z","added_via":"web","geo":{"keywords":["OncoPrism","Cofactor Genomics","Healthcare","Diagnostics","Biotech","Oncology","Genomics","Medical Devices"],"canonical_facts":["Product of Cofactor Genomics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:46:01.904Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/categories/diagnostics"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/categories/medical-devices"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:46:01.904Z","updated_at":"2026-09-05T07:46:01.904Z"}},{"listing_type":"product","name":"Oncobox Dx","slug":"oncobox-dx","tagline":"Precision oncology platform that profiles tumor DNA and RNA to rank 170+ targeted and immunotherapy drugs for each patient.","description":"Oncobox Dx analyzes tumor genomics to predict the effectiveness of over 170 targeted and immunotherapy drugs, generating a personalized drug ranking with molecular abnormality reports and clinical trial outcomes for oncologists. The system has been validated in retrospective and prospective trials with hundreds of late-stage cancer patients. Testing is accessed through affiliated clinics that send tumor samples to the Oncobox laboratory for comprehensive genomic profiling. Oncobox holds a USPTO patent for its genetic information analysis platform.\n\nOncobox Dx is a product of Oncobox.","url":"https://oncobox.com/","is_stealth":false,"normalized_domain":"oncobox.com","normalized_url_key":"oncobox.com","parent_slug":"oncobox","parent":{"slug":"oncobox","name":"Oncobox","listing_type":"company","profile_url":"/companies/oncobox"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Personalized cancer drug selection","Late-stage cancer treatment planning","Tumor genomic profiling","Biomarker discovery for drug response"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://oncobox.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://oncobox.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Oncology","Biotech","Drug discovery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:40:40.022Z","added_via":"web","geo":{"keywords":["Oncobox Dx","Oncobox","Healthcare","Diagnostics","Oncology","Biotech","Drug discovery"],"canonical_facts":["Product of Oncobox"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:40:40.022Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/categories/diagnostics"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:40:40.022Z","updated_at":"2026-09-05T07:40:40.022Z"}},{"listing_type":"product","name":"FidoCure","slug":"fidocure-service","tagline":"Precision oncology platform for dogs using genomic testing to identify targeted cancer therapies beyond chemo and radiation.","description":"FidoCure uses genomic testing and tumor profiling to identify cancer-driving mutations in dogs, then recommends personalized targeted therapeutic options. Developed by One Health Company, the platform is used by veterinarians and oncologists and has built the largest proprietary canine cancer dataset in the world from thousands of treated dogs. FidoCure has sequenced and treated dogs across thousands of clinics with near-100% oncologist adoption.\n\nFidoCure is a product of FidoCure®.","url":"https://fidocure.com/","is_stealth":false,"normalized_domain":"fidocure.com","normalized_url_key":"fidocure.com","parent_slug":"fidocure","parent":{"slug":"fidocure","name":"FidoCure®","listing_type":"company","profile_url":"/companies/fidocure"},"type_data":{"product_kind":"service","platforms":["web"],"free_tier":false,"open_source":false,"use_cases":["canine cancer treatment","genomic sequencing for dogs","veterinary oncology","targeted therapy recommendations for pets"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://fidocure.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://fidocure.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Veterinary","Oncology","Precision Medicine","Healthcare Services"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:31:04.043Z","added_via":"web","geo":{"keywords":["FidoCure","FidoCure®","Healthcare","Veterinary","Oncology","Precision Medicine","Healthcare Services"],"canonical_facts":["Product of FidoCure®"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:31:04.043Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"healthcare-services","name":"Healthcare Services","note":null,"profile_url":"/categories/healthcare-services"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"precision-medicine","name":"Precision Medicine","note":null,"profile_url":"/categories/precision-medicine"},{"kind":"product_category","slug":"veterinary","name":"Veterinary","note":null,"profile_url":"/categories/veterinary"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:31:04.043Z","updated_at":"2026-09-05T07:31:04.043Z"}},{"listing_type":"product","name":"MICA","slug":"mica-clear-gene","tagline":"Advanced signal-processing software and rapid test kits for clinical labs to process more samples at lower cost.","description":"Clear Gene's MICA product line provides clinical labs with tools to increase testing throughput and reduce costs using existing equipment. MICA Software uses an advanced signal-processing algorithm to make more reliable Ct calls across multiple tests and instruments via a single interface. MICA Test Kits are rapid, sensitive drop-in PCR replacements. MICA-Direct Kits provide reagents for 5-minute RNA extractions compatible with PCR and isothermal tests. The company also applies genomics and machine learning to detect residual disease in solid tumors.\n\nMICA is a product of Clear Gene.","url":"https://cleargene.com/","is_stealth":false,"normalized_domain":"cleargene.com","normalized_url_key":"cleargene.com","parent_slug":"clear-gene","parent":{"slug":"clear-gene","name":"Clear Gene","listing_type":"company","profile_url":"/companies/clear-gene"},"type_data":{"product_kind":"other","platforms":["web"],"free_tier":false,"open_source":false,"use_cases":["PCR lab throughput improvement","RNA extraction","Ct call reliability","residual cancer detection","oncology diagnostics"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://cleargene.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://cleargene.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","AI","Women's Health","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:30:17.196Z","added_via":"web","geo":{"keywords":["MICA","Clear Gene","Healthcare","Diagnostics","AI","Women's Health","Oncology"],"canonical_facts":["Product of Clear Gene"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:30:17.196Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/categories/diagnostics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"womens-health","name":"Women's Health","note":null,"profile_url":"/categories/womens-health"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:30:17.196Z","updated_at":"2026-09-05T07:30:17.196Z"}},{"listing_type":"product","name":"Asher Bio","slug":"asher-bio-product","tagline":"Cis-targeted immunotherapies that selectively activate specific immune cell types for cancer and autoimmune diseases.","description":"Asher Bio develops cis-targeted immunotherapies designed to activate only the immune cell types needed for a therapeutic effect. Their approach uses two-molecule targeting on the same immune cell—an immunomodulatory receptor and a cell-specific target—to achieve selectivity and reduce toxicity compared to conventional immunotherapies. Their lead program, etakafusp alfa (formerly AB248), is a cis-targeted IL-2 that preferentially activates CD8+ effector T cells, currently in Phase 1a/1b clinical trials with promising anti-tumor activity and a tolerable safety profile.\n\nAsher Bio is a product of Asher Bio.","url":"https://asherbio.com/","is_stealth":false,"normalized_domain":"asherbio.com","normalized_url_key":"asherbio.com","parent_slug":"asher-bio","parent":{"slug":"asher-bio","name":"Asher Bio","listing_type":"company","profile_url":"/companies/asher-bio"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Cancer immunotherapy","Autoimmune disease treatment","CD8+ T cell activation"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://asherbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://asherbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Therapeutics","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:14:28.300Z","added_via":"web","geo":{"keywords":["Asher Bio","Asher Bio","Healthcare","Biotech","Therapeutics","Oncology"],"canonical_facts":["Product of Asher Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:14:28.300Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:14:28.300Z","updated_at":"2026-09-05T07:14:28.300Z"}},{"listing_type":"product","name":"Zealth AI","slug":"zealth-ai","tagline":"Healthcare AI strategy and product leadership services helping organizations define AI roadmaps and build AI-enabled products.","description":"Zealth AI offers healthcare-focused AI strategy and product leadership services. They help healthcare organizations define AI roadmaps, develop AI-enabled products, and implement responsible AI practices. The focus is on aligning AI initiatives with clinical value, regulatory considerations, and operational feasibility to drive measurable health outcomes.\n\nZealth AI is a product of Zealth.","url":"https://www.zealth-ai.com/","is_stealth":false,"normalized_domain":"zealth-ai.com","normalized_url_key":"zealth-ai.com","parent_slug":"zealth","parent":{"slug":"zealth","name":"Zealth","listing_type":"company","profile_url":"/companies/zealth"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["AI roadmap definition for healthcare organizations","AI-enabled product development","Responsible AI implementation","Clinical value alignment"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.zealth-ai.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.zealth-ai.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","AI","Consulting","Health Tech","Healthcare IT","Remote","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:55:53.222Z","added_via":"web","geo":{"keywords":["Zealth AI","Zealth","Healthcare","AI","Consulting","Health Tech","Healthcare IT","Remote","Oncology"],"canonical_facts":["Product of Zealth"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:55:53.222Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"consulting","name":"Consulting","note":null,"profile_url":"/categories/consulting"},{"kind":"product_category","slug":"health-tech","name":"Health Tech","note":null,"profile_url":"/categories/health-tech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"healthcare-it","name":"Healthcare IT","note":null,"profile_url":"/categories/healthcare-it"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"remote","name":"Remote","note":null,"profile_url":"/categories/remote"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:55:53.222Z","updated_at":"2026-09-05T06:55:53.222Z"}},{"listing_type":"product","name":"Yemaachi Biotech","slug":"yemaachi-biotech","tagline":"Africa-led cancer innovation company leveraging underrepresented genomic data to advance precision oncology globally.","description":"Yemaachi Biotech pioneers clinical genomic research across Africa to advance precision oncology. The company collects and sequences biological samples from the most genetically diverse population on earth to build a first-of-its-kind cancer knowledgebase on African people. It partners with public, private, and non-profit organizations globally to diversify cancer diagnostics and therapeutics. Offices are in Ghana, USA, and Kenya.\n\nYemaachi Biotech is a product of Yemaachi Biotechnology.","url":"https://www.yemaachi.com/","is_stealth":false,"normalized_domain":"yemaachi.com","normalized_url_key":"yemaachi.com","parent_slug":"yemaachi-biotechnology","parent":{"slug":"yemaachi-biotechnology","name":"Yemaachi Biotechnology","listing_type":"company","profile_url":"/companies/yemaachi-biotechnology"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Cancer genomics research","Precision oncology diagnostics","Optimizing diagnostic tests for African populations","Drug discovery partnerships"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.yemaachi.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.yemaachi.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Oncology","Genomics","Diagnostics","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:55:50.534Z","added_via":"web","geo":{"keywords":["Yemaachi Biotech","Yemaachi Biotechnology","Biotech","Healthcare","Oncology","Genomics","Diagnostics","Therapeutics"],"canonical_facts":["Product of Yemaachi Biotechnology"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:55:50.534Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/categories/diagnostics"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:55:50.534Z","updated_at":"2026-09-05T06:55:50.534Z"}},{"listing_type":"product","name":"REPROSENT","slug":"reprosent-platform","tagline":"Observational data layer capturing real-world patient symptom experience between clinical visits for oncology and biopharma teams.","description":"REPROSENT is an EHR-agnostic, non-interventional platform that deploys as an observational overlay on existing clinical trials and care programs. Patients complete 1-2 minute home check-ins describing their experience in plain language mapped to structured scales; treating teams review concise summaries while existing safety workflows remain unchanged. The platform generates longitudinal, dose-aware, AI-ready tolerability data for biopharma development teams working on advanced oncology therapies including ADCs and immunotherapies where intermittent clinic check-ins miss day-to-day toxicities.\n\nREPROSENT is a product of REPROSENT.","url":"https://www.reprosent.com/","is_stealth":false,"normalized_domain":"reprosent.com","normalized_url_key":"reprosent.com","parent_slug":"reprosent","parent":{"slug":"reprosent","name":"REPROSENT","listing_type":"company","profile_url":"/companies/reprosent"},"type_data":{"product_kind":"saas","platforms":["web"],"open_source":false,"use_cases":["patient-reported outcomes","oncology clinical data","drug tolerability monitoring","real-world evidence","dose optimization"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.reprosent.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.reprosent.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Clinical Data","AI","Biometrics","Consumer Health Services","Digital Health","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:50:43.740Z","added_via":"web","geo":{"keywords":["REPROSENT","REPROSENT","Healthcare","Biotech","Clinical Data","AI","Biometrics","Consumer Health Services","Digital Health","Oncology"],"canonical_facts":["Product of REPROSENT"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:50:43.740Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biometrics","name":"Biometrics","note":null,"profile_url":"/categories/biometrics"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"clinical-data","name":"Clinical Data","note":null,"profile_url":"/categories/clinical-data"},{"kind":"product_category","slug":"consumer-health-services","name":"Consumer Health Services","note":null,"profile_url":"/categories/consumer-health-services"},{"kind":"product_category","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/categories/digital-health"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:50:43.740Z","updated_at":"2026-09-05T06:50:43.740Z"}},{"listing_type":"product","name":"Serinus Biosciences","slug":"serinus-biosciences-service","tagline":"AI platform using systems biology to design combination cancer therapies that overcome treatment resistance.","description":"Serinus Biosciences develops an AI platform primed with systems biology knowledge to identify how cancer cells evolve treatment resistance and design combination therapies to overcome resistance escape routes. The platform aims to deliver safer, more effective combinations that reach patients faster. The company is founded by MIT PhDs and is based in New York. Limited public product detail is available on the website.\n\nSerinus Biosciences is a product of Serinus Biosciences.","url":"https://www.serinus.bio/","is_stealth":false,"normalized_domain":"serinus.bio","normalized_url_key":"serinus.bio","parent_slug":"serinus-biosciences","parent":{"slug":"serinus-biosciences","name":"Serinus Biosciences","listing_type":"company","profile_url":"/companies/serinus-biosciences"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Cancer combination therapy design","Treatment resistance research","Drug discovery partnerships"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.serinus.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.serinus.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Oncology","AI","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:23:28.324Z","added_via":"web","geo":{"keywords":["Serinus Biosciences","Serinus Biosciences","Biotech","Healthcare","Oncology","AI","Therapeutics"],"canonical_facts":["Product of Serinus Biosciences"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:23:28.324Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:23:28.324Z","updated_at":"2026-09-05T06:23:28.324Z"}},{"listing_type":"product","name":"Eugit Therapeutics","slug":"eugit-therapeutics-product","tagline":"Tissue-targeting drug delivery platform using T cell receptors to treat inflammatory diseases with precision.","description":"Eugit Therapeutics develops a tissue-targeting drug delivery platform designed to address non-specific drugs that cause toxicity and clinical trial failures in tissue-specific inflammatory diseases. The platform uses T cell receptors to deliver drugs with precision to diseased tissues, enhancing safety and efficacy. Initial focus is on Inflammatory Bowel Disease, with plans to initiate clinical trials within two years. Co-founded by George Church, Professor at Harvard Medical School.\n\nEugit Therapeutics is a product of Eugit Therapeutics.","url":"https://www.eugittx.com/","is_stealth":false,"normalized_domain":"eugittx.com","normalized_url_key":"eugittx.com","parent_slug":"eugit-therapeutics","parent":{"slug":"eugit-therapeutics","name":"Eugit Therapeutics","listing_type":"company","profile_url":"/companies/eugit-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Inflammatory Bowel Disease treatment","tissue-specific drug delivery","reducing drug toxicity"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotechnology","Therapeutics","Synthetic Biology","Cell Therapy","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:11:54.340Z","added_via":"web","geo":{"keywords":["Eugit Therapeutics","Eugit Therapeutics","Healthcare","Biotechnology","Therapeutics","Synthetic Biology","Cell Therapy","Oncology"],"canonical_facts":["Product of Eugit Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:11:54.340Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:11:54.340Z","updated_at":"2026-09-05T06:11:54.340Z"}},{"listing_type":"product","name":"Alixia","slug":"alixia-product","tagline":"Biopharma research platform developing tumor ecosystem disruptors that target cancer drug resistance across multiple cell types.","description":"Alixia is a biopharma company developing a portfolio of therapeutic compounds targeting the tumor microenvironment as an ecological system rather than a single mutation. Their research platform integrates biology, biophysics, computational chemistry, and clinical input to identify lead compounds that disrupt metabolic and inflammatory triggers in both cancer and quasi-cancerous cells. Current programs span various stages of preclinical development addressing multiple age-related diseases at the intersection of cancer, aging, and immunity.\n\nAlixia is a product of Alixia.","url":"https://www.alixia.com/","is_stealth":false,"normalized_domain":"alixia.com","normalized_url_key":"alixia.com","parent_slug":"alixia","parent":{"slug":"alixia","name":"Alixia","listing_type":"company","profile_url":"/companies/alixia"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Cancer drug resistance treatment","Tumor microenvironment targeting","Neurodegenerative disease therapy"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Oncology","Drug Discovery","Healthcare","Therapeutics","Biotechnology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:59:45.505Z","added_via":"web","geo":{"keywords":["Alixia","Alixia","Biotech","Oncology","Drug Discovery","Healthcare","Therapeutics","Biotechnology"],"canonical_facts":["Product of Alixia"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:59:45.505Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:59:45.505Z","updated_at":"2026-09-05T05:59:45.505Z"}},{"listing_type":"product","name":"Modulari-T","slug":"modulari-t-product","tagline":"Biotech platform developing next-generation modular immune receptors and in vivo gene delivery vehicles to overcome CAR-T therapy limitations.","description":"Modulari-T develops two core technologies for cell and gene therapy: MARC (Modular Actuation Receptor Complex), a next-generation immune receptor with separate targeting and signaling, on/off control, bispecific options, and reduced exhaustion validated across five cell types; and MoVe (Modular Vector), the first rationally designed in vivo delivery vehicle for gene therapy that avoids liver toxicity and precisely targets immune or non-immune cells. The platform is designed to expand cell therapies beyond hematologic malignancies to solid tumors, autoimmune diseases, and other conditions.\n\nModulari-T is a product of Modulari-T.","url":"https://modularit.bio/","is_stealth":false,"normalized_domain":"modularit.bio","normalized_url_key":"modularit.bio","parent_slug":"modulari-t","parent":{"slug":"modulari-t","name":"Modulari-T","listing_type":"company","profile_url":"/companies/modulari-t"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["cancer cell therapy","gene delivery","autoimmune disease treatment","next-generation CAR-T development"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Healthcare","Cell Therapy","Gene Therapy","Synthetic Biology","Therapeutics","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:49:53.383Z","added_via":"web","geo":{"keywords":["Modulari-T","Modulari-T","Biotech","Healthcare","Cell Therapy","Gene Therapy","Synthetic Biology","Therapeutics","Oncology"],"canonical_facts":["Product of Modulari-T"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:49:53.383Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:49:53.383Z","updated_at":"2026-09-05T05:49:53.383Z"}},{"listing_type":"product","name":"Adventris Pharmaceuticals","slug":"adventris-pharmaceuticals-product","tagline":"Off-the-shelf cancer vaccines targeting KRAS and other poorly immunogenic oncogenes to prevent and treat common cancers.","description":"Adventris Pharmaceuticals develops off-the-shelf cancer vaccines using a platform that solves the challenge of targeting poorly immunogenic oncogenes. Its first vaccine targets KRAS, the most common cancer oncogene. The long-term vision is annual pan-cancer vaccines for adults that could prevent the majority of cancer deaths. The company is in early-stage development and backed by Y Combinator (Winter 2023).\n\nAdventris Pharmaceuticals is a product of Adventris Pharmaceuticals.","url":"https://www.adventris.com/","is_stealth":false,"normalized_domain":"adventris.com","normalized_url_key":"adventris.com","parent_slug":"adventris-pharmaceuticals","parent":{"slug":"adventris-pharmaceuticals","name":"Adventris Pharmaceuticals","listing_type":"company","profile_url":"/companies/adventris-pharmaceuticals"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["KRAS-driven cancer treatment","pan-cancer vaccination","cancer prevention"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.adventris.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.adventris.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology","Drug Discovery and Delivery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:41:10.057Z","added_via":"web","geo":{"keywords":["Adventris Pharmaceuticals","Adventris Pharmaceuticals","Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology","Drug Discovery and Delivery"],"canonical_facts":["Product of Adventris Pharmaceuticals"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:41:10.057Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:41:10.057Z","updated_at":"2026-09-05T05:41:10.057Z"}},{"listing_type":"product","name":"Velorum Therapeutics","slug":"velorum-therapeutics-product","tagline":"Drug pipeline targeting heme biology to treat porphyrias, cancer, and tissue injury.","description":"Velorum Therapeutics is a clinical-stage drug development company focused on unlocking the biology of heme, an iron-containing molecule essential for oxygen transport and cellular detoxification. The pipeline targets diseases caused by dysregulated heme synthesis or transport, including porphyrias (EPP and XLP), cancer growth driven by heme consumption, and organ toxicity from heme release. Velorum aims to develop transformative medicines for patients with unmet medical needs.\n\nVelorum Therapeutics is a product of Velorum Therapeutics.","url":"https://www.velorumtx.com/","is_stealth":false,"normalized_domain":"velorumtx.com","normalized_url_key":"velorumtx.com","parent_slug":"velorum-therapeutics","parent":{"slug":"velorum-therapeutics","name":"Velorum Therapeutics","listing_type":"company","profile_url":"/companies/velorum-therapeutics"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["treating porphyrias (EPP, XLP)","targeting cancer driven by heme consumption","treating organ toxicity from heme release"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.velorumtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.velorumtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:40:26.901Z","added_via":"web","geo":{"keywords":["Velorum Therapeutics","Velorum Therapeutics","Healthcare","Biotech","Drug Discovery","Therapeutics","Oncology"],"canonical_facts":["Product of Velorum Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:40:26.901Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:40:26.901Z","updated_at":"2026-09-05T05:40:26.901Z"}},{"listing_type":"product","name":"Kopra Bio","slug":"kopra-bio-product","tagline":"Cancer immunotherapy that genetically engineers viruses to turn cancer cells into biofactories for their own destruction.","description":"Kopra Bio develops genetically engineered virus-based cancer immunotherapies that reprogram tumor cells to produce agents of their own destruction. The company's lead program targets glioblastoma, the most aggressive form of brain cancer, using technology developed at UCSF. In preclinical models, Kopra Bio's treatment improved survival from 0% with the current FDA-approved standard of care to 90%. The company is pursuing a next-generation immunotherapy with a market opportunity analogous to Keytruda, the $25B/year cancer drug.\n\nKopra Bio is a product of Kopra Bio.","url":"https://www.kopra.bio/","is_stealth":false,"normalized_domain":"kopra.bio","normalized_url_key":"kopra.bio","parent_slug":"kopra-bio","parent":{"slug":"kopra-bio","name":"Kopra Bio","listing_type":"company","profile_url":"/companies/kopra-bio"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["glioblastoma treatment","cancer immunotherapy"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Oncology","Gene Therapy","Synthetic Biology","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:24:12.987Z","added_via":"web","geo":{"keywords":["Kopra Bio","Kopra Bio","Healthcare","Biotech","Oncology","Gene Therapy","Synthetic Biology","Therapeutics"],"canonical_facts":["Product of Kopra Bio"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:24:12.987Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/categories/synthetic-biology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:24:12.987Z","updated_at":"2026-09-05T05:24:12.987Z"}},{"listing_type":"product","name":"Omanta","slug":"omanta-service","tagline":"Personalized scientific research service that assembles a dedicated PhD team to investigate each patient's complex cancer, rare disease, or unresolved…","description":"Omanta provides a full research team for patients who have exhausted standard options, with PhD scientists selected for each case's specific biology to gather and interpret all records, imaging, pathology, and molecular data. The team uses whole-genome sequencing, single-cell RNA sequencing, spatial transcriptomics, and spatial proteomics to build a detailed molecular profile, then cross-references findings against a 5,000-sample reference cohort and a structured evidence dataset. Diagnostic gaps are identified and additional testing is coordinated with the patient's clinical team. Results are translated into a living therapeutic roadmap shared with the patient's physicians to inform real care decisions.\n\nOmanta is a product of Omanta.","url":"https://omanta.com/","is_stealth":false,"normalized_domain":"omanta.com","normalized_url_key":"omanta.com","parent_slug":"omanta","parent":{"slug":"omanta","name":"Omanta","listing_type":"company","profile_url":"/companies/omanta"},"type_data":{"product_kind":"service","platforms":["web"],"free_tier":false,"open_source":false,"use_cases":["advanced cancer research for individual patients","rare disease investigation","unresolved diagnosis workup","personalized molecular profiling","clinical trial matching","treatment roadmap planning"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://omanta.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://omanta.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Oncology","Rare Disease","AI","Digital Health","Health & Wellness"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T04:32:16.893Z","added_via":"web","geo":{"keywords":["Omanta","Omanta","Healthcare","Oncology","Rare Disease","AI","Digital Health","Health & Wellness"],"canonical_facts":["Product of Omanta"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T04:32:16.893Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/categories/digital-health"},{"kind":"product_category","slug":"health-and-wellness","name":"Health & Wellness","note":null,"profile_url":"/categories/health-and-wellness"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"rare-disease","name":"Rare Disease","note":null,"profile_url":"/categories/rare-disease"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T04:32:16.893Z","updated_at":"2026-09-05T04:32:16.893Z"}},{"listing_type":"product","name":"Gamgee","slug":"gamgee-product","tagline":"Personalized mRNA cancer vaccines for dogs designed computationally from each dog's tumor genome to target cancer-driving mutations.","description":"Gamgee's platform sequences a dog's tumor and healthy DNA, identifies the mutations driving the cancer, and designs a personalized mRNA vaccine protocol administered by a veterinary oncologist with ongoing response monitoring. The company manages the entire process end-to-end from intake review and vet outreach through tissue collection, genomic analysis, and vaccine creation. Gamgee is currently running clinical trials in Australia and accepting registrations of interest worldwide. Its first product is designated ze-ets-001.\n\nGamgee is a product of Gamgee.","url":"https://www.gamgee.io/","is_stealth":false,"normalized_domain":"gamgee.io","normalized_url_key":"gamgee.io","parent_slug":"gamgee","parent":{"slug":"gamgee","name":"Gamgee","listing_type":"company","profile_url":"/companies/gamgee"},"type_data":{"product_kind":"other","platforms":["web"],"open_source":false,"use_cases":["personalized cancer treatment for dogs","veterinary oncology","mRNA vaccine therapy for pets","genomic cancer analysis"]},"logo":null,"links":[],"entry_points":[{"kind":"signup","url":"https://www.gamgee.io/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"signup","url":"https://www.gamgee.io/","audience":"human","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biotech","Veterinary","Genomics","Oncology","AI","Drug Discovery and Delivery"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T04:10:11.347Z","added_via":"web","geo":{"keywords":["Gamgee","Gamgee","Healthcare","Biotech","Veterinary","Genomics","Oncology","AI","Drug Discovery and Delivery"],"canonical_facts":["Product of Gamgee"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T04:10:11.347Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"genomics","name":"Genomics","note":null,"profile_url":"/categories/genomics"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"veterinary","name":"Veterinary","note":null,"profile_url":"/categories/veterinary"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T04:10:11.347Z","updated_at":"2026-09-05T04:10:11.347Z"}},{"listing_type":"product","name":"FinalDose","slug":"finaldose-product","tagline":"Programmable DNA drug platform designed to search and destroy cancer cells upon DNA recognition, targeting previously undruggable mutations.","description":"FinalDose is developing a programmable drug molecule that can be configured with any diseased genetic code to search and destroy cells upon DNA recognition. The company claims the platform can unlock approximately 80% of previously undruggable cancer targets and is starting with all cancers. The site links to a whitepaper describing the complete architecture for cancer therapy.\n\nFinalDose is a product of FinalDose.","url":"https://www.finaldose.ai/","is_stealth":false,"normalized_domain":"finaldose.ai","normalized_url_key":"finaldose.ai","parent_slug":"finaldose","parent":{"slug":"finaldose","name":"FinalDose","listing_type":"company","profile_url":"/companies/finaldose"},"type_data":{"product_kind":"other","open_source":false,"docs_url":"https://www.finaldose.ai/whitepaper/","use_cases":["cancer therapy","undruggable target engagement","DNA-targeted cancer treatment"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.finaldose.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"docs","url":"https://www.finaldose.ai/whitepaper/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.finaldose.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":{"kind":"docs","url":"https://www.finaldose.ai/whitepaper/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}},"founders":[],"media":null,"categories":["Healthcare","Biotech","Therapeutics","Gene Therapy","Oncology","Artificial Intelligence","Genetic Engineering"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T04:09:36.463Z","added_via":"web","geo":{"keywords":["FinalDose","FinalDose","Healthcare","Biotech","Therapeutics","Gene Therapy","Oncology","Artificial Intelligence","Genetic Engineering"],"canonical_facts":["Product of FinalDose"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T04:09:36.463Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/categories/artificial-intelligence"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"genetic-engineering","name":"Genetic Engineering","note":null,"profile_url":"/categories/genetic-engineering"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"oncology","name":"Oncology","note":null,"profile_url":"/categories/oncology"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T04:09:36.463Z","updated_at":"2026-09-05T04:09:36.463Z"}}],"total":20,"limit":50,"offset":0}